Valion Bio Inc (VBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Sales | 0 | 126 | 140 | 334 | 357 |
| Cost of Goods | N/A | 82 | 110 | 167 | 352 |
| Gross Profit | N/A | 44 | 30 | 167 | 5 |
| Operating Expenses | -302 | 1,557 | 1,406 | 1,815 | 2,601 |
| Operating Income | -298 | -1,431 | -1,266 | -1,481 | -2,244 |
| Other Income | 6 | 0 | 0 | 0 | 1 |
| Pre-tax Income | -292 | -1,431 | -1,266 | -1,481 | -2,243 |
| Net Income Continuous | -292 | -1,431 | -1,266 | -1,481 | -2,243 |
| Net Income | $-1,477 | $-1,431 | $-1,266 | $-1,481 | $-2,243 |
| EPS Basic Total Ops | 6.77 | -3.93 | -5.37 | -17.15 | 149.05 |
| EPS Basic Continuous Ops | 10.90 | -3.93 | -5.37 | -17.15 | 149.05 |
| EPS Diluted Total Ops | 6.77 | -3.93 | -5.37 | -17.15 | 149.05 |
| EPS Diluted Continuous Ops | 10.90 | -3.93 | -5.37 | -17.15 | 149.05 |
| EPS Diluted Before Non-Recurring Items | N/A | -3.91 | -5.44 | N/A | N/A |
| EBITDA(a) | $575 | $-1,430 | $-1,234 | $-1,435 | $-2,197 |